Sevoflurane, sold under the brand name Sevorane, among others, is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset. [8] .

2023年6月5日 · Sevoflurane is a volatile anesthetic that provides hypnosis, amnesia, analgesia, akinesia, and autonomic blockade during surgical and procedural interventions. This activity describes the mode of action of sevoflurane and highlights the role of the interprofessional team in the safe administration of anesthesia.

2024年2月20日 · Sevoflurane. Generic name: Sevoflurane [ see-voe-FLOO-rane ] Brand names: Sojourn, Ultane Drug class: General anesthetics. Medically reviewed by Drugs.com. Last updated on Feb 20, 2024. Uses; Before taking; Warnings; Dosage; Side effects; Overdose; Uses of Sevoflurane: It is used to put you to sleep for surgery. It is used to cause sleep during ...

2025年3月1日 · Inhaled sevoflurane is used to cause general anesthesia (loss of consciousness) before and during surgery. It belongs to the group of medicines known as general anesthetics. This medicine is to be given only by or under the direct supervision of a doctor.

七氟醚（英語： Sevoflurane ）為一種非易燃、氣味香甜的鹵代醚麻醉藥，可以誘導和維持全身麻醉。其藥力起效和消退速度甚快，僅次於地氟醚 [1] 。本藥通常與笑氣和氧氣混合後，以吸入形式施用。

What Is Sevoflurane and How Does It Work? Sevoflurane is a prescription medicine used as anesthesia during surgery. What Are Dosages of Sevoflurane? Adult and pediatric dosage. Liquid. Anesthesia. Adult dosage. Pediatric dosage. Dosage Considerations – Should be Given as Follows: What Are Side Effects Associated with Using Sevoflurane?

Sevoflurane is a inhalation anaesthetic agent used for induction and maintenance of general anesthesia during surgical procedures.

Sevoflurane is an ether inhalation anesthetic agent used to induce and maintain general anesthesia. It is a volatile, non-flammable compound with a low solubility profile and blood/gas partition coefficient. Sevoflurane was patented in 1972, was approved for clinical use in Japan in 1990, and approved by the FDA in 1996.

2023年5月31日 · Sevoflurane, USP, volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization, is a halogenated general inhalation anesthetic drug. Sevoflurane, USP is fluoromethyl 2,2,2,-trifluoro-1-(trifluoromethyl) ethyl ether and its structural formula is:

2025年1月7日 · Sevoflurane is a volatile halogenated general anaesthetic that has a minimum alveolar concentration (MAC) value ranging from 1.4% to 3.3%. It alters the activity of fast synaptic neurotransmitter receptors like nicotinic acetylcholine, GABA, and glutamate.